Findings from a prospective phase 2 clinical trial show that isatuximab (Sarclisa), an anti-CD38 monoclonal antibody, is an effective and well-tolerated treatment for patients with relapsed and/or ...
Intellia Therapeutics, Inc. (NASDAQ:NTLA) ranks among the most oversold biotech stocks to invest in. On November 11, Jones ...
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending Amvuttra ...
The stock has a low forward earnings multiple and a higher -- yet still attractive -- EV-to-EBITDA ratio. Even if Pfizer ...
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third-quarter ...
In 1978, the Falcons were heavy underdogs but pulled off an improbable win over the Pioneers at Veterans Stadium. While the ...
Verywell Health on MSN
The Rare Heart Condition That's Often Mistaken for Normal Aging
Heart failure is a condition that many people face with age, but cases of a rare heart condition tied to a genetic mutation are on the rise. Learn what transthyretin amyloid cardiomyopathy (ATTR-CM) ...
Biotech is on track to deliver this year one of its best years of annual returns since the sector’s heady days of the Covid ...
The CAP committee recommended that pathologists use mass spectrometry to determine the subtype for amyloidosis patients being considered for treatment.
A recent study reveals cognitive behavioral therapy significantly enhances lung cancer patients' ability to manage dyspnea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback